Detalles de la búsqueda
1.
Rationally designed immunogens enable immune focusing to the SARS-CoV-2 receptor binding motif
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-435440
2.
Naive human B cells can neutralize SARS-CoV-2 through recognition of its receptor binding domain
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-429458
3.
Engineered receptor binding domain immunogens elicit pan-coronavirus neutralizing antibodies
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-415216
4.
Circulating SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21251704
5.
COVID-19 neutralizing antibodies predict disease severity and survival
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20213512
6.
Ultra-Sensitive High-Resolution Profiling of Anti-SARS-CoV-2 Antibodies for Detecting Early Seroconversion in COVID-19 Patients
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20083691
7.
Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunity
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-444848
8.
Preferential expansion of cross-reactive pre-existing switched memory B cells that recognize the SARS-CoV-2 Omicron variant Spike protein
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21268554
9.
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21267755
10.
Rapid generation of potent antibodies by autonomous hypermutation in yeast
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-378778
11.
SARS-CoV-2 Serosurveys: How antigen, isotype and threshold choices affect the outcome
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22279787
12.
An adjuvanted SARS-CoV-2 RBD nanoparticle elicits neutralizing antibodies and fully protective immunity in aged mice
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-459664
13.
Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-434840
14.
Dynamics and significance of the antibody response to SARS-CoV-2 infection
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20155374
15.
Clinical Sensitivity and Interpretation of PCR and Serological COVID-19 Diagnostics for Patients Presenting to the Hospital
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20135723
16.
Immunogenicity of an AAV-based, room-temperature stable, single dose COVID-19 vaccine in mice and non-human primates
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-422952
17.
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-201616
18.
The Prolyl-tRNA Synthetase Inhibitor Halofuginone Inhibits SARS-CoV-2 Infection
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-436522
19.
The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-424729
Resultados
1 -
19
de 19
1
Próxima >
>>